Acciones Shanrong Biotechnology Corp. Other OTC
Acciones
SRBT
US81946R1077
Holding Companies
Ventas 2008 | 692 mil 641 mil | Ventas 2009 | 1,32 M 1,23 M | Capitalización | 11,62 M 10,76 M |
---|---|---|---|---|---|
Resultado Neto 2008 | -2 M -1,85 M | Resultado Neto 2009 | -5 M -4,63 M | VE / Ventas 2008 | 45,1 x |
Deuda neta 2008 | 2,53 M 2,34 M | Deuda neta 2009 | 2,18 M 2,02 M | VE / Ventas 2009 | 10,4 x |
P/E ratio 2008 |
-10,5
x | P/E ratio 2009 |
-2,03
x | Empleados | - |
Rendimiento 2008 * |
-
| Rendimiento 2009 |
-
| Flotante | 38,95 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 31/08/21 |
Qingping Zheng
BRD | Director/Board Member | - | - |
Guenter Volgger
PRN | Corporate Officer/Principal | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 31/08/21 |
Qingping Zheng
BRD | Director/Board Member | - | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+154,80 % | 8131,76 M | |
+2,33 % | 984 M | |
+41,91 % | 883 M | |
+18,23 % | 786 M | |
+2,16 % | 667 M | |
+5,03 % | 631 M | |
-.--% | 600 M | |
+8,61 % | 528 M | |
-.--% | 500 M |